Pulmonary Arterial Hypertension market forecast
May 17, 2019
Pulmonary Arterial Hypertension Therapies
Pulmonary Arterial Hypertension (PAH) is a chronic, life-alarming disease that advances over time. It is a rare disease characterized by the increased blood pressure in the arteries of the lungs. It is somehow different from normal high pressure in a way that blood pressure rises only in the arteries that carry blo...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
